List of Genetic Analysis/Screening Companies in Japan - 3
Search through the full list with powerful filtering options
Want this in Excel? Get Quote NowCompany | About |
---|---|
Logomix Chuo-Ku Harumi 4-7-4, CROSS DOCK HARUMI 1F, Tokyo, 104-0053, JP | Logomix is a synthetic biology company, reshaping the landscape of human genome engineering. Its Geno-Writing™ platform enables precise engineering of Mb-scale genomic sequences within human cells, and thus facilitates the development of super-functionalized cells for the fields of cell therapy, regenerative medicine and any future cell-based therapies. |
Reprocell 8F KDX Shin-Yokohama 381 Bldg., 3-8-11,Shin-Yokohama, Kohoku-ku, Yokohama, 222-0033, JP | REPROCELL supports nearly the entire workflow of stem cell research and pre-clinical drug development. Our unique portfolio includes access to human tissues (BioServe) and human tissue testing (Biopta), in addition to stem cell culture media, reprogramming technologies, reagents, and iPSC-derived cell types (Stemgent). With our deep knowledge of stem cell biology, bioengineered (3D) tissue models (Alvetex) cell differentiation, and pharmacology, REPROCELL is a recognized leader in cutting-edge tools and services to accelerate regenerative medicine and drug development. The newly formed REPROCELL Medical business unit is developing a suite of reagents and services to meet the growing need for clinical-grade products and services that are appropriate for regenerative medicine. In addition, our labs offer diagnostic services for a variety of tests related to tissue compatibility and other biomarkers. And finally, REPROCELL also offers a GMP iPSC master cell bank manufacturing service. *** REPROCELL went public on the Japan JASDAQ in June 2013. Stemgent, BioServe and Reinnervate became parts of REPROCELL in 2014. Biopta was then acquired in 2015. |
Takara Bio Shiga, Japan | Takara Bio Inc. is committed to improving the human condition through biotechnology. Starting as the biomedical business of Takara Shuzo, a fermentation and beverage company founded in 1925 (now Takara Holdings Company, Inc.), Takara Bio has focused on developing research tools for the life sciences, cell and gene therapy technologies, and nutraceuticals since its launch in 1967. The three business units of TAKARA BIO INC are: • Genetic Engineering Research - manufactures and sells research reagents and scientific instruments used by biotechnology researchers worldwide, as well as contract research services. • Agribio - produces and sells health food products whose functionality have been proven by biotechnology, and conducts a mushroom business based on technologies for large-scale mushroom production. • Gene Medicine - conducts clinical development projects to work toward commercializing cell and gene therapies centered on a highly efficient gene transduction method and a lymphocyte expansion-culture system, both using RetroNectin® reagent. |